S
Sajni Josson
Researcher at Cedars-Sinai Medical Center
Publications - 30
Citations - 1957
Sajni Josson is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 20, co-authored 30 publications receiving 1759 citations. Previous affiliations of Sajni Josson include University of Kentucky & Emory University.
Papers
More filters
Journal ArticleDOI
Aerosol size and chemical characteristics at Mumbai,India, during the INDOEX-IFP (1999)
TL;DR: In this paper, the size and chemical characteristics of surface aerosols measured at Mumbai during the Indian Ocean Experiment-Intensive Field Phase (INDOEX-IFP),January-March 1999 were reported.
Journal ArticleDOI
Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis.
Sajni Josson,Murali Gururajan,Shian-Ying Sung,P. Hu,C. Shao,Haiyen E. Zhau,C. Liu,Jake Lichterman,P. Duan,Quanlin Li,Andre Rogatko,Edwin M. Posadas,Christopher L. Haga,Leland W.K. Chung +13 more
TL;DR: Stromal fibroblasts derived miR-409-induced tumorigenesis, epithelial-to-mesenchymal transition and stemness of the epithelial cancer cells in vivo, and appears to be an attractive therapeutic target to block the vicious cycle of tumor–stromal interactions that plagues prostate cancer patients.
Journal ArticleDOI
Radiation modulation of microRNA in prostate cancer cell lines.
TL;DR: MicroRNAs are gene regulators and play an important role in response to cellular stress and are studied for their role in regulation of cell survival and apoptosis.
Journal ArticleDOI
MicroRNA 125b inhibition of B cell differentiation in germinal centers.
Murali Gururajan,Christopher L. Haga,Sabyasachi Das,Chuen Miin Leu,Daniel J. Hodson,Sajni Josson,Martin R Turner,Max D. Cooper +7 more
TL;DR: Findings suggest that miR-125b promotes B lymphocyte diversification in GC by inhibiting premature utilization of essential transcription factors for plasma cell differentiation.
Journal ArticleDOI
Tumor-stroma co-evolution in prostate cancer progression and metastasis.
Sajni Josson,Yasuhiro Matsuoka,Yasuhiro Matsuoka,Leland W.K. Chung,Leland W.K. Chung,Haiyen E. Zhau,Haiyen E. Zhau,Ruoxiang Wang +7 more
TL;DR: In the laboratory, it is demonstrated that prostate cancer cells co-evolve in their genotypic and phenotypic characters with stroma and acquire osteomimetic properties allowing them to proliferate and survive in the skeleton as bone metastasis.